Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart Spiessens

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Contemporary Clinical Trials|September 14, 2010
Adjusted significance levels for subgroup analyses in clinical trialsBart Spiessens, Muriel Debois
Statistics in Medicine|February 19, 2003
A comparison of group sequential methods for binary longitudinal dataBart Spiessens, Emmanuel Lesaffre, Geert Verbeke
Biometrics|September 17, 2002
Group sequential methods for an ordinal logistic random-effects model under misspecificationBart Spiessens, Emmanuel Lesaffre, Geert Verbeke, et al.
Statistics in Medicine|October 13, 2005
Tutorial in biostatistics: the self-controlled case series methodHeather J Whitaker, C Paddy Farrington, Bart Spiessens, et al.
BMC Infectious Diseases|August 8, 2024
Unbiased identification of risk factors for invasive Escherichia coli disease using machine learningErik Clarke, Christel Chehoud, Najat Khan, et al.
Biometrical Journal. Biometrische Zeitschrift|October 21, 2016
Testing interaction between treatment and high-dimensional covariates in randomized clinical trialsAndrea Callegaro, Bart Spiessens, Benjamin Dizier, et al.
Human Vaccines|February 18, 2009
Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: a pooled analysis of 11 clinical trialsDominique Descamps, Karin Hardt, Bart Spiessens, et al.
Expert Review of Vaccines|September 26, 2023
Harmonizing the collection of solicited adverse events in prophylactic vaccine clinical trialsBrigitte Cheuvart, Bart Spiessens, Roy van Heesbeen, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 7, 2024
Safety, reactogenicity, and immunogenicity of different doses of 10-valent Extraintestinal Pathogenic Escherichia Coli (ExPEC10V) bioconjugate vaccine (VAC52416) in healthy Japanese adults aged 60-85 years in a randomized, double-blind, phase 1 studyMiwa Haranaka, Atsushi Momose, Yoshikazu Nakayama, et al.
Vaccine|June 21, 2020
Characterization of Escherichia coli isolates potentially covered by ExPEC4V and ExPEC10V, that were collected from post-transrectal ultrasound-guided prostate needle biopsy invasive urinary tract and bloodstream infectionsElie Saade, Stefan Gravenstein, Curtis J Donskey, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Contemporary Clinical Trials|September 14, 2010
Adjusted significance levels for subgroup analyses in clinical trialsBart Spiessens, Muriel Debois
Statistics in Medicine|February 19, 2003
A comparison of group sequential methods for binary longitudinal dataBart Spiessens, Emmanuel Lesaffre, Geert Verbeke
Biometrics|September 17, 2002
Group sequential methods for an ordinal logistic random-effects model under misspecificationBart Spiessens, Emmanuel Lesaffre, Geert Verbeke, et al.
Statistics in Medicine|October 13, 2005
Tutorial in biostatistics: the self-controlled case series methodHeather J Whitaker, C Paddy Farrington, Bart Spiessens, et al.
BMC Infectious Diseases|August 8, 2024
Unbiased identification of risk factors for invasive Escherichia coli disease using machine learningErik Clarke, Christel Chehoud, Najat Khan, et al.
Biometrical Journal. Biometrische Zeitschrift|October 21, 2016
Testing interaction between treatment and high-dimensional covariates in randomized clinical trialsAndrea Callegaro, Bart Spiessens, Benjamin Dizier, et al.
Human Vaccines|February 18, 2009
Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: a pooled analysis of 11 clinical trialsDominique Descamps, Karin Hardt, Bart Spiessens, et al.
Expert Review of Vaccines|September 26, 2023
Harmonizing the collection of solicited adverse events in prophylactic vaccine clinical trialsBrigitte Cheuvart, Bart Spiessens, Roy van Heesbeen, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 7, 2024
Safety, reactogenicity, and immunogenicity of different doses of 10-valent Extraintestinal Pathogenic Escherichia Coli (ExPEC10V) bioconjugate vaccine (VAC52416) in healthy Japanese adults aged 60-85 years in a randomized, double-blind, phase 1 studyMiwa Haranaka, Atsushi Momose, Yoshikazu Nakayama, et al.
Vaccine|June 21, 2020
Characterization of Escherichia coli isolates potentially covered by ExPEC4V and ExPEC10V, that were collected from post-transrectal ultrasound-guided prostate needle biopsy invasive urinary tract and bloodstream infectionsElie Saade, Stefan Gravenstein, Curtis J Donskey, et al.
Pageof 4